119 related articles for article (PubMed ID: 26767432)
1. Enlarging Multiple Neoplastic Skin Growths.
Feinstein EG; Zhou M; Setabutr P
JAMA Ophthalmol; 2016 Mar; 134(3):337-8. PubMed ID: 26767432
[No Abstract] [Full Text] [Related]
2. Basal cell carcinoma rebound after cessation of vismodegib in a nevoid basal cell carcinoma syndrome patient.
Wolfe CM; Green WH; Cognetta AB; Hatfield HK
Dermatol Surg; 2012 Nov; 38(11):1863-6. PubMed ID: 22805146
[No Abstract] [Full Text] [Related]
3. Oral hedgehog-pathway inhibitors for basal-cell carcinoma.
Lear JT
N Engl J Med; 2012 Jun; 366(23):2225-6. PubMed ID: 22670909
[No Abstract] [Full Text] [Related]
4. Vismodegib in advanced basal-cell carcinoma.
Henkin RI
N Engl J Med; 2012 Sep; 367(10):970; author reply 970-1. PubMed ID: 22931271
[No Abstract] [Full Text] [Related]
5. 9q22.3 Microdeletion Syndrome with Multiple Basal Cell Carcinomas Treated with Vismodegib: Three Key Messages in One Patient.
Kieny A; Kremer V; Scheidecker S; Lipsker D
Acta Derm Venereol; 2018 Feb; 98(2):287-288. PubMed ID: 29057423
[No Abstract] [Full Text] [Related]
6. Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome.
Tang JY; Mackay-Wiggan JM; Aszterbaum M; Yauch RL; Lindgren J; Chang K; Coppola C; Chanana AM; Marji J; Bickers DR; Epstein EH
N Engl J Med; 2012 Jun; 366(23):2180-8. PubMed ID: 22670904
[TBL] [Abstract][Full Text] [Related]
7. Effect of Calcium Channel Blockade on Vismodegib-Induced Muscle Cramps.
Ally MS; Tang JY; Lindgren J; Acosta-Raphael M; Rezaee M; Chanana AM; Epstein EH
JAMA Dermatol; 2015 Oct; 151(10):1132-4. PubMed ID: 26200175
[No Abstract] [Full Text] [Related]
8. Surgical excision after neoadjuvant therapy with vismodegib for a locally advanced basal cell carcinoma and resistant basal carcinomas in Gorlin syndrome.
Chang AL; Atwood SX; Tartar DM; Oro AE
JAMA Dermatol; 2013 May; 149(5):639-41. PubMed ID: 23677114
[No Abstract] [Full Text] [Related]
9. Targeting the hedgehog pathway to treat basal cell carcinoma.
Geeraert P; Williams JS; Brownell I
J Drugs Dermatol; 2013 May; 12(5):519-23. PubMed ID: 23652945
[TBL] [Abstract][Full Text] [Related]
10. Comment on basal cell carcinoma rebound after cessation of vismodegib in an individual with basal cell nevus syndrome.
Ally MS; Wysong A; Tang JY; Aasi S
Dermatol Surg; 2013 Sep; 39(9):1413-4. PubMed ID: 23682843
[No Abstract] [Full Text] [Related]
11. Vismodegib for periocular and orbital basal cell carcinoma.
Gill HS; Moscato EE; Chang AL; Soon S; Silkiss RZ
JAMA Ophthalmol; 2013 Dec; 131(12):1591-4. PubMed ID: 24136169
[TBL] [Abstract][Full Text] [Related]
12. Mesenteric cysts in naevoid basal cell carcinoma syndrome: a mimic of metastatic disease.
Rajan N; Brown S; Ward S; Hainsworth P; Hodgkinson P; Pieniazek P; Husain A; Plummer R
Br J Dermatol; 2016 Mar; 174(3):684-5. PubMed ID: 26473628
[No Abstract] [Full Text] [Related]
13. Intermittent Vismodegib Therapy in Basal Cell Nevus Syndrome.
Yang X; Dinehart SM
JAMA Dermatol; 2016 Feb; 152(2):223-4. PubMed ID: 26509945
[No Abstract] [Full Text] [Related]
14. Histologic changes in basal cell carcinoma after treatment with vismodegib.
Aldabagh B; Yu J; Perkocha LA; Arron S
Dermatol Surg; 2013 Nov; 39(11):1703-5. PubMed ID: 23879864
[No Abstract] [Full Text] [Related]
15. Emerging treatments and signaling pathway inhibitors.
Tang JY; Marghoob AA
Semin Cutan Med Surg; 2011 Dec; 30(4 Suppl):S14-8. PubMed ID: 22177102
[TBL] [Abstract][Full Text] [Related]
16. Vismodegib (Erivedge) for basal cell carcinoma.
Med Lett Drugs Ther; 2012 Jul; 54(1394):53-4. PubMed ID: 22777303
[No Abstract] [Full Text] [Related]
17. Indications and limitations of vismodegib for basal cell carcinoma.
Yin VT; Sniegowski M; Esmaeli B
JAMA Ophthalmol; 2014 Jul; 132(7):905-6. PubMed ID: 25010179
[No Abstract] [Full Text] [Related]
18. Indications and limitations of vismodegib for basal cell carcinoma--reply.
Gill HS; Moscato EE; Silkiss RZ
JAMA Ophthalmol; 2014 Jul; 132(7):906. PubMed ID: 25010181
[No Abstract] [Full Text] [Related]
19. [A new drug for basal cell carcinoma].
Witte F
Schweiz Monatsschr Zahnmed; 2013; 123(12):1104-6. PubMed ID: 24730087
[No Abstract] [Full Text] [Related]
20. Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome.
Ozgur OK; Yin V; Chou E; Ball S; Kies M; William WN; Migden M; Thuro BA; Esmaeli B
Am J Ophthalmol; 2015 Aug; 160(2):220-227.e2. PubMed ID: 25935097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]